Endoscopic management of obesity: Impact of endoscopic sleeve gastroplasty on weight loss and co-morbidities at six months and one year.
Fiche publication
Date publication
janvier 2023
Journal
Journal of visceral surgery
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MUTTER Didier
Tous les auteurs :
Alexandre F, Lapergola A, Vannucci M, Pizzicannella M, D'Urso A, Saviano A, Mutter D, Vix M, Perretta S
Lien Pubmed
Résumé
Endoscopic sleeve gastroplasty (ESG) is one of the new minimally invasive endoscopic treatments aimed at inducing weight loss. Its effectiveness in terms of weight loss is proven. Gastric volume reduction and delayed gastric emptying are the mechanisms that drive weight loss. However, potential benefits for co-morbidities in relation to weight loss after ESG are still being investigated. This study aims to evaluate the effect of ESG procedures on major obesity-associated co-morbidities, and on some biological parameters.
Mots clés
Bariatric endoscopy, Co-morbidity, Endoscopic sleeve gastroplasty, Obesity
Référence
J Visc Surg. 2023 01 30;: